# Circulating and Adipose Tissue miRNAs in Women With Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training

PMID: 32848854
Journal: Frontiers in physiology
Published: 2020
Authors: Lionett S, Kiel IA, Camera DM, Vanky E, Parr EB, Lydersen S, Hawley JA, Moholdt T

## Question

How do selected circulating and adipose-tissue miRNAs differ in women with PCOS and how do they respond to 16 weeks of low- or high-volume HIT?

## Summary

This randomized trial in women with PCOS compared 16 weeks of low-volume HIT, high-volume HIT, and non-exercise control. High-volume HIT improved VO2peak, low-volume HIT reduced circulating miR-27b, and neither protocol changed body composition or adipose-tissue miRNA expression.

## Population

- Women aged 18-45 years with PCOS; separate matched non-PCOS comparison group for baseline profiles
- Sample size: 54
- Age: 18-45 years eligible
- Sex: Female
- Fitness level: Not undertaking regular endurance training >=2 sessions/week
- Health status: PCOS by Rotterdam criteria; non-PCOS controls normally menstruating without hyperandrogenism or polycystic ovaries

## Methodology

- Two-center randomized controlled exercise trial with matched non-PCOS comparison for baseline miRNA profiles
- 16 weeks
- NTNU Trondheim, Norway and Australian Catholic University, Melbourne, Australia
- Randomized and controlled study design.

## Protocol

- LV-HIT and HV-HIT.
- Modality: Aerobic HIT.
- Work intervals: LV-HIT 1 minute; HV-HIT 4 minutes.
- Recovery: LV-HIT 1 minute passive or low-intensity walking; HV-HIT 3 minutes active recovery at about 70% HRmax.
- Sets or repetitions: LV-HIT 10; HV-HIT 4.
- Intensity: Maximal sustainable intensity or 90-95% HRmax.
- Session duration: LV-HIT about 33 minutes including warm-up/cool-down; HV-HIT about 41 minutes if each bout was followed by active recovery.
- Frequency: 3 sessions/week.
- Program length: 16 weeks.
- Non-exercise control.
- Program length: 16 weeks.

## Outcomes

### c-miR-27b
Status: mixed
Women with PCOS had higher basal circulating miR-27b; LV-HIT reduced it, but HV-HIT did not.

PCOS vs non-PCOS p=0.006; LV-HIT 0.5-fold decrease p=0.007.

### VO2peak
Status: improved
Only HV-HIT significantly increased VO2peak.

VO2peak L/min +9%, p=0.008.

### Body composition
Status: no clear change
No body composition changes were detected.

### AT miRNAs
Status: no clear change
Gluteal and abdominal adipose-tissue miRNAs were not altered by either HIT protocol.

## Practical Insights

- Four-by-four-minute HIT is more clearly tied to VO2peak improvement in this PCOS sample than the 10 x 1-minute protocol.
- Mechanistic biomarker changes should not be equated with user-facing health outcomes.

## Limitations

- Small groups
- Targeted miRNA panel
- Mechanistic endpoints
- PCOS-specific population

## Safety And Adherence

- Article did not report adverse events, injuries, dropout counts, or actual attendance/adherence rates.
- Participants were screened out for cardiovascular disease, other endocrine disorders, pregnancy/breastfeeding within 24 weeks, exercise-limiting ailments or injuries, and relevant medication use without washout.
- At least one weekly session was supervised and Polar M400 heart-rate monitors were worn during all sessions to ensure protocol compliance.

## Original Sources

- [PubMed](https://pubmed.ncbi.nlm.nih.gov/32848854/) (pubmed)
- [DOI](https://doi.org/10.3389/fphys.2020.00904) (doi)
- [PMC full text](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406716/) (full text)

## Agent Guidance

Preserve the paper-level scope of this note. Do not generalize beyond the population, protocol, measured outcomes, and limitations above.